Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection

Vaccine

Volumn 32, Issue 30, 2014, Pages 3780-3786

  Lanzieri, Tatiana M ^a   Bialek, Stephanie R ^a   Ortega Sanchez, Ismael R ^a   Gambhir, Manoj ^a,b,c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Congenital infection; Cytomegalovirus; Mathematical model; Vaccination impact

Indexed keywords

CYTOMEGALOVIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BIRTH RATE; BRAZIL; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; DRUG EFFICACY; FEMALE; HUMAN; MALE; MATHEMATICAL MODEL; POPULATION; PRIORITY JOURNAL; REINFECTION; SENSITIVITY ANALYSIS; SEROPREVALENCE; UNITED STATES; VACCINATION; VIRUS TRANSMISSION; CHILD; CYTOMEGALOVIRUS INFECTIONS; INFANT; PREGNANCY; PRESCHOOL CHILD; PREVENTION AND CONTROL; PROCEDURES; THEORETICAL MODEL; VERTICAL TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; BRAZIL; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; FEMALE; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MODELS, THEORETICAL; PREGNANCY; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84922265773     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.05.014     Document Type: Article

References (28)

1. Enders G., Bader U., Lindemann L., Schalasta G., Daiminger A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001, 21:362-377.
2. Boppana S.B., Pass R.F., Britt W.J., Stagno S., Alford C.A. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992, 11:93-99.
3. Arvin A.M., Fast P., Myers M., Plotkin S., Rabinovich R. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis 2004, 39:233-239.
4. Grosse S.D., Ortega-Sanchez I.R., Bialek S.R., Dollard S.C. The economic impact of congenital CMV infection: methods and estimates. Cytomegaloviruses: from molecular pathogenesis to intervention 2013, Caister Academic Press. M.J. Reddehase (Ed.).
5. Vaccines for the 21st century: a tool for decision making 2000, The National Academies Press.
6. Schleiss M.R. Cytomegalovirus vaccine development. Curr Top Microbiol Immunol 2008, 325:361-382.
7. Garnett G.P., Cousens S., Hallett T.B., Steketee R., Walker N. Mathematical models in the evaluation of health programmes. Lancet 2011, 378:515-525.
8. Cannon M.J., Hyde T.B., Schmid D.S. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 2011, 21:240-255.
9. Ross S.A., Arora N., Novak Z., Fowler K.B., Britt W.J., Boppana S.B. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 2010, 201:386-389.
10. Fowler K.B., Stagno S., Pass R.F. Maternal immunity and prevention of congenital cytomegalovirus infection. J Am Med Assoc 2003, 289:1008-1011.
11. Azevedo R.S., Amaku M. Modelling immunization strategies with cytomegalovirus vaccine candidates. Epidemiol Infect 2011, 139:1818-1826.
12. Sinclair J. Human cytomegalovirus: latency and reactivation in the myeloid lineage. J Clin Virol 2008, 41:180-185.
13. Vochem M., Hamprecht K., Jahn G., Speer C.P. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 1998, 17:53-58.
14. Peckham C.S., Johnson C., Ades A., Pearl K., Chin K.S. Early acquisition of cytomegalovirus infection. Arch Dis Child 1987, 62:780-785.
15. Bate S.L., Dollard S.C., Cannon M.J. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010, 50:1439-1447.
16. Almeida L.N., Azevedo R.S., Amaku M., Massad E. Cytomegalovirus seroepidemiology in an urban community of Sao Paulo, Brazil. Rev Saude Publica 2001, 35:124-129.
17. Heffernan J.M., Smith R.J., Wahl L.M. Perspectives on the basic reproductive ratio. J R Soc Interface 2005, 2:281-293.
18. Diekmann O., Heesterbeek J.A., Roberts M.G. The construction of next-generation matrices for compartmental epidemic models. J R Soc Interface 2010, 7:873-885.
19. Colugnati F.A., Staras S.A., Dollard S.C., Cannon M.J. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007, 7:71.
20. Krause P.R., Bialek S.R., Boppana S.B., Griffiths P.D., Laughlin C.A., Ljungman P., et al. Priorities for CMV vaccine development. Vaccine 2013.
21. Haber M., Longini I.M., Halloran M.E. Measures of the effects of vaccination in a randomly mixing population. Int J Epidemiol 1991, 20:300-310.
22. Mossong J., Hens N., Jit M., Beutels P., Auranen K., Mikolajczyk R., et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5:e74.
23. Griffiths P., Plotkin S., Mocarski E., Pass R., Schleiss M., Krause P., et al. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine 2013, 31(Suppl. 2):B197-B203.
24. Griffiths P.D., McLean A., Emery V.C. Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine 2001, 19:1356-1362.
25. Yamamoto A.Y., Mussi-Pinhata M.M., Boppana S.B., Novak Z., Wagatsuma V.M., Oliveira Pde F., et al. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 2010, 202:297. e1-8.
26. Pass R.F., Zhang C., Evans A., Simpson T., Andrews W., Huang M.L., et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009, 360:1191-1199.
27. Sabbaj S., Pass R.F., Goepfert P.A., Pichon S. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis 2011, 203:1534-1541.
28. Schleiss M.R. Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?. J Infect Dis 2011, 203:1513-1516.